PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.25%
Revenue growth of 4.25% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
6.66%
Gross profit growth of 6.66% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
45.88%
EBIT growth of 45.88% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
51.13%
Operating income growth of 51.13% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
46.91%
Net income growth of 46.91% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
46.89%
EPS growth exceeding 1.5x Healthcare median of 4.76%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
46.89%
Diluted EPS growth exceeding 1.5x Healthcare median of 4.45%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
-0.00%
Share reduction while Healthcare median is 0.19%. Seth Klarman would see a relative advantage if others are diluting.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend cuts while Healthcare median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
68.51%
10Y CAGR of 68.51% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
64.78%
5Y CAGR of 64.78% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
35.69%
3Y CAGR of 35.69% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
100.00%
OCF/share CAGR of 100.00% while Healthcare median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
202.11%
Net income/share CAGR exceeding 1.5x Healthcare median of 0.65% over a decade. Joel Greenblatt might see a standout compounder of earnings.
95.22%
5Y net income/share CAGR > 1.5x Healthcare median of 8.46%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
40.35%
3Y net income/share CAGR > 1.5x Healthcare median of 4.59%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
201.46%
Equity/share CAGR of 201.46% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
125.07%
5Y equity/share CAGR of 125.07% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
58.34%
3Y equity/share CAGR of 58.34% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.90%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
-6.06%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
1.11%
Asset growth of 1.11% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
3.35%
BV/share growth of 3.35% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-4.77%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-1.60%
SG&A decline while Healthcare grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.